Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study

OBJECTIVE: To compare the efficacy and safety profiles of sorafenib and apatinib in patients with intermediate- and advanced-stage hepatocellular carcinoma (HCC). METHODS: This was a single-center, retrospective study where we collected the clinical data of 72 patients, diagnosed with intermediate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizhuo, Gou, Qing, Xu, Rongde, Chen, Xiaoming, Zhou, Zejian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003281/
https://www.ncbi.nlm.nih.gov/pubmed/29928132
http://dx.doi.org/10.2147/OTT.S161023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003281/
https://www.ncbi.nlm.nih.gov/pubmed/29928132
http://dx.doi.org/10.2147/OTT.S161023

Ejemplares similares